Is Taysha Gene Therapies, Inc. (TSHA) a Buy, Sell, or Hold?
NASDAQ : TSHA
Taysha Gene Therapies, Inc.
$5.96 USD
-$0.01 (-0.17%)
- Volume
- 2.81M
- Average Volume
- 3.12M
- Market Capitalization
- $1.49B
- P/E Ratio
- -15.57
- Dividend Yield
- 0.00%
- Price Target
- $14.50
- Year High
- $7.30
- Year Low
- $2.34
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $14.04
3333332"{?
p/.m7yd f,0=
Annual earnings financials
TSHA financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
TSHA Estimated and Actual Revenue by Quarter
TSHA Estimated and Actual EPS by Quarter
TSHA Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 6 | -21.08M | -21.08M | -21.08M | -21.08M | -21.08M | -21.08M |
| 2027-09-30 | 6 | -4.55M | -4.55M | -4.55M | -4.55M | -4.55M | -4.55M |
| 2027-06-30 | 6 | -576K | -576K | -576K | -576K | -576K | -576K |
| 2027-03-31 | 6 | -480K | -480K | -480K | -480K | -480K | -480K |
| 2026-12-31 | 11 | -630K | -630K | -630K | -630K | -630K | -630K |
| 2026-09-30 | 12 | -408K | -408K | -408K | -408K | -408K | -408K |
TSHA Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 6 | -29.85M | -29.85M | -29.85M | 167.39M | 167.39M | 167.39M |
| 2027-09-30 | 6 | -44.52M | -44.52M | -44.52M | 36.14M | 36.14M | 36.14M |
| 2027-06-30 | 6 | -47.66M | -47.66M | -47.66M | 4.57M | 4.57M | 4.57M |
| 2027-03-31 | 6 | -45.83M | -45.83M | -45.83M | 3.81M | 3.81M | 3.81M |
| 2026-12-31 | 11 | -44.25M | -44.25M | -44.25M | 5M | 5M | 5M |
| 2026-09-30 | 12 | -42.97M | -39.39M | -42.97M | 3.24M | 3.24M | 3.24M |
TSHA Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2027-12-31 | 6 | 35.13M | 35.13M | 35.13M | 1 | -0.081429 | -0.081429 | -0.081429 |
| 2027-09-30 | 6 | 7.58M | 7.58M | 7.58M | 1 | -0.12143 | -0.12143 | -0.12143 |
| 2027-06-30 | 6 | 960K | 960K | 960K | 1 | -0.13 | -0.13 | -0.13 |
| 2027-03-31 | 6 | 800K | 800K | 800K | 1 | -0.125 | -0.125 | -0.125 |
| 2026-12-31 | 11 | 1.05M | 1.05M | 1.05M | 1 | -0.1207 | -0.1207 | -0.1207 |
| 2026-09-30 | 12 | 680K | 680K | 680K | 3 | -0.11721 | -0.10744 | -0.11721 |